CorMedix
CRMD
#7338
Rank
HK$4.42 B
Marketcap
HK$56.81
Share price
-1.90%
Change (1 day)
-31.00%
Change (1 year)

Earnings for CorMedix (CRMD)

Earnings in 2026 (TTM): HK$1.58 Billion

According to CorMedix's latest financial reports the company's current earnings are HK$0.45 Billion. In 2025 the company made an earning of HK$1.17 Billion, an increase over its 2024 earnings that were of -HK$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CorMedix from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$1.58 B34.92%
2025 HK$1.17 B-876.29%
2024 -HK$0.16 Billion-58.3%
2023 -HK$0.37 Billion53%
2022 -HK$0.24 Billion2.81%
2021 -HK$0.24 Billion8.32%
2020 -HK$0.22 Billion26.53%
2019 -HK$0.17 Billion-19.89%
2018 -HK$0.22 Billion-18.72%
2017 -HK$0.26 Billion34.56%
2016 -HK$0.2 Billion34.88%
2015 -HK$0.15 Billion-11.08%
2014 -HK$0.17 Billion124.69%
2013 -HK$71.44 Million144.91%
2012 -HK$29.17 Million-48.41%
2011 -HK$56.55 Million-33.29%
2010 -HK$84.76 Million78.42%
2009 -HK$47.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Becton Dickinson
BDX
HK$11.73 B 635.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
HK$0.10 B-93.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-HK$0.75 Billion-146.75%๐Ÿ‡บ๐Ÿ‡ธ USA